發(fā)布時(shí)間：2018-04-08 18:36

  本文選題：時(shí)間給藥法　切入點(diǎn)：COPD穩(wěn)定期　出處：《云南中醫(yī)學(xué)院》2017年碩士論文

【摘要】：目的:觀察時(shí)間給藥法治療肺腎氣陰兩虛型老年COPD穩(wěn)定期的臨床療效。方法:本研究將60例肺腎氣陰兩虛型老年COPD穩(wěn)定期患者按照隨機(jī)原則分為治療組與對(duì)照組。對(duì)照組:常規(guī)服用中藥湯劑補(bǔ)肺定喘湯,每日1劑,早、中、晚3次分服;治療組:服用中藥湯劑補(bǔ)肺定喘湯,每日1劑,早寅時(shí)(北京時(shí)間4-5時(shí),地方時(shí)間與北京時(shí)間有時(shí)差需校正),晚酉時(shí)(北京時(shí)間18-19時(shí))2次分服。兩組療程均為14天。將患者治療前后的肺功能FEV1、中醫(yī)證候療效、CAT積分進(jìn)行觀察分析比較。結(jié)果:兩組病例在治療前后中醫(yī)證候療效比較,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。研究結(jié)果顯示:治療組在中醫(yī)證候療效方面優(yōu)于對(duì)照組。兩組病例治療前后中醫(yī)證候積分比較、肺功能FEV1、m MRC積分、CAT積分比較,差異均有統(tǒng)計(jì)學(xué)意義(P0.05),研究結(jié)果顯示:治療組在改善以上各方面均優(yōu)于對(duì)照組。結(jié)論:治療組在改善肺功能FEV1、中醫(yī)證候、咳嗽、咳痰、氣短、呼吸困難、乏力等癥狀、m MRC積分及CAT評(píng)分優(yōu)于對(duì)照組。治療過(guò)程中,兩組病例的安全性指標(biāo)治療前后無(wú)顯著變化,說(shuō)明兩組用藥均安全。因此,治療肺腎氣陰兩虛型老年COPD穩(wěn)定期時(shí)間給藥法優(yōu)于常規(guī)給藥法,且用藥安全。
[Abstract]:Objective: to observe the clinical effect of time administration on the stable period of COPD in elderly patients with deficiency of lung and kidney qi and yin.Time difference between local time and Beijing time need to be corrected, late unitary time (18-19 hours Beijing time) 2 times.The course of treatment was 14 days in both groups.The pulmonary function FEV 1 and cat score of TCM syndrome were observed and compared before and after treatment.Results: there was significant difference between the two groups before and after treatment.The results showed that the treatment group was superior to the control group in the curative effect of TCM syndrome.The comparison of TCM syndromes and FEV1m MRC and cat scores before and after treatment in the two groups were statistically significant (P 0.05). The results showed that the treatment group was superior to the control group in improving the above aspects.Conclusion: the treatment group is superior to the control group in improving the pulmonary function FEV1, TCM syndromes, cough, expectoration, shortness of breath, dyspnea, fatigue and other symptoms such as MRC score and CAT score.In the course of treatment, the safety indexes of the two groups were not significantly changed before and after treatment, indicating that both groups were safe.Therefore, the treatment of the elderly patients with deficiency of lung and kidney qi and yin was superior to the routine administration method in the stable period of COPD, and the medication was safe.
【學(xué)位授予單位】：云南中醫(yī)學(xué)院
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R563.9

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 楊立春;劉瑛;;蘇子降氣湯合七味都?xì)馔柚委熉宰枞苑渭膊〖毙约又仄谂R床觀察[J];新疆中醫(yī)藥;2012年05期

2 李建生;李素云;余學(xué)慶;;慢性阻塞性肺疾病中醫(yī)診療指南(2011版)[J];中醫(yī)雜志;2012年01期

3 張偉;;老年人呼吸道感染的預(yù)防[J];保健醫(yī)苑;2011年04期

4 張?chǎng)?賈英杰;張艷;謝廣茹;;寅時(shí)用參麥液對(duì)非小細(xì)胞肺癌患者化療的影響[J];遼寧中醫(yī)雜志;2007年08期

5 王華;趙景春;韓書(shū)芝;;氧化/抗氧化失衡與慢性阻塞性肺疾病[J];河北醫(yī)藥;2007年05期

6 沈美意;用藥時(shí)辰與藥效的關(guān)系[J];浙江中西醫(yī)結(jié)合雜志;2004年03期

7 丁英兒;時(shí)辰藥理學(xué)與臨床合理用藥[J];中國(guó)醫(yī)院藥學(xué)雜志;2003年10期

8 顧[?;試論子午流注學(xué)說(shuō)在咳喘癥護(hù)理中的運(yùn)用[J];解放軍護(hù)理雜志;2002年06期

9 徐艷,李喜桂;給藥時(shí)間與藥效[J];河南醫(yī)藥信息;2002年19期

10 田正鑒,徐幼明,李亞清;慢性阻塞性肺疾病中醫(yī)病機(jī)探微[J];湖北中醫(yī)學(xué)院學(xué)報(bào);2001年01期

相關(guān)會(huì)議論文 前1條

1 忻耀杰;滕磊;;喉源性咳嗽時(shí)間節(jié)律性的臨床觀察與探討[A];第六次全國(guó)中西醫(yī)結(jié)合變態(tài)反應(yīng)學(xué)術(shù)大會(huì)論文匯編[C];2013年

，

本文編號(hào)：1722839